Emerging Market Woes Overshadow Coca-Cola's Q2 EPS Beat

Comments
Loading...

SunTrust slashed its estimates on The Coca-Cola Co KO as emerging markets woes overshadowed the beverage giant's second quarter EPS beat.

The company reported adjusted EPS of $0.60, above SunTrust estimate of $0.57 and the consensus estimate of $0.58 on better than-expected gross margin (60.5 percent vs. 59.8 percent estimate).

In addition, Coke's net sales of $11.524 billion (-5.1 percent YoY) was above SunTrust estimate of $11.48 billion (-5.5 percent YoY) but below the consensus estimate of $11.64 billion (-4.2 percent YoY).

"The weak volume performance was due to declining volumes in large emerging markets (notably China, Brazil, Argentina), as both developed and developing markets posted positive volumes and price/mx," analyst William Chappell wrote in a note.

Specifically, in China, the company not only hit by weaker overall demand, but also inventory destocking from wholesalers which negatively impacted Coke's bottling operations. Notably, China is Coke's largest international bottling operation and the company still owns over one third of the system.

Going forward, Coke said it plans to offer more affordable packaging and products to address the macro-slowdown in its emerging markets, but it does not expect to see a meaningful improvement in China for the foreseeable future.

Chappell also cut his 2016 and 2017 EPS estimates to $1.89 and $1.95, respectively (from $1.91 and $2.02).

That said, Chappell maintained his Buy rating on the stock saying he still believes the refranchising of Coke's bottling network will position the company as a higher margin business, more focused on its core concentrate business.

"We note that during 2Q, KO's core concentrate organic growth, which excludes revenue from owned bottlers, was actually up 4% during the quarter. We view the 4% growth as a good proxy of the company's potential post transition," Chappell added.

Overview Rating:
Speculative
50%
Technicals Analysis
66
0100
Financials Analysis
40
0100
Overview
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!